A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1997
11/18/1997	CA1339546C Recombinant hybrid immunogloblin molecules an method of use
11/13/1997	WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997	WO1997042255A1 Polymer powders redispersible in aqueous solution
11/13/1997	WO1997041899A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997	WO1997041898A1 Targeted combination immunotherapy of cancer
11/13/1997	WO1997041897A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
11/13/1997	WO1997041896A2 Inclusion complexes of aryl-heterocyclic salts
11/13/1997	WO1997041895A2 TREATMENT OF ASTHMA WITH TNFR-Ig
11/13/1997	WO1997041894A1 Micellar aqueous composition and method for solubilizing hydrophobic drug
11/13/1997	WO1997041893A1 Composition containing a nerve fibre reactivity modulating compound
11/13/1997	WO1997041843A2 Medicated chewing gum with a pleasant taste containing an inclusion complex
11/13/1997	WO1997041840A1 Prodrug compositions and drug delivery methods using synthetic receptors
11/13/1997	WO1997041839A1 Taste masked liquid suspensions
11/13/1997	WO1997041837A2 Microparticles
11/13/1997	WO1997041836A1 Pharmaceutical compositions for the sustained release of insoluble active principles
11/13/1997	WO1997041835A1 Improvement in the taste of active pharmaceutical ingredients
11/13/1997	WO1997041834A1 Cationic virosomes as transfer system for genetic material
11/13/1997	WO1997041832A1 Suspension of sparingly water-soluble acidic drug
11/13/1997	WO1997037640A3 Uniform drug delivery therapy
11/13/1997	WO1997032607A3 Activated linkers and methods for making and purifying the same
11/13/1997	WO1997031655A3 Modified cytokines for therapeutic use
11/13/1997	DE19619313A1 Ion-exchange resin coated or loaded with polymer with counterions
11/13/1997	DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance
11/13/1997	CA2253930A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones
11/13/1997	CA2253904A1 Targeted combination immunotherapy of cancer
11/13/1997	CA2253798A1 Polymer powders redispersible in aqueous solution
11/13/1997	CA2253737A1 Micellar aqueous composition and method for solubilizing hydrophobic drug
11/13/1997	CA2253561A1 Cationic virosomes as transfer system for genetic material
11/13/1997	CA2253557A1 Treatment of asthma with tnfr-ig
11/13/1997	CA2253386A1 Improvement in the taste of active pharmaceutical ingredients
11/13/1997	CA2253377A1 Pharmaceutical compositions for the sustained release of insoluble active principles
11/13/1997	CA2253260A1 Suspension of sparingly water-soluble acidic drug
11/13/1997	CA2253204A1 Prodrug compositions and drug delivery methods using synthetic receptors
11/13/1997	CA2251129A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997	CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997	CA2204067A1 Chlorhexidine glucomate-containing, stabilized aqueous pharmaceutical preparations
11/12/1997	EP0806206A1 Aqueous compositions containing ciprofloxacine, and related use and process
11/12/1997	EP0806202A1 Controlled release pharmaceutical composition containing stabilized lipophilic matrices
11/12/1997	EP0805690A1 Method for selective methionine starvation of malignant cells in mammals
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997	EP0805676A1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
11/12/1997	EP0805675A1 Directly compressible high load acetaminophen formulations
11/12/1997	EP0805628A1 Receptor specific transepithelial transport of immunogens
11/12/1997	EP0659080A4 Method and composition for the treatment of hair loss.
11/12/1997	EP0480982B2 Vaccines and vectors with liquid active principles containing an oil which can be metabolised
11/12/1997	CN1164829A Transfer of molecules into cytosol of cells
11/12/1997	CN1164828A Oral cyclosporin formulations
11/12/1997	CN1164389A Extended release formulation
11/12/1997	CN1036375C Local drug delivery film for periodontal treatment
11/11/1997	US5686600 Antibodies which bind to insect gut proteins and their use
11/11/1997	US5686589 Esters and amides of substituted phenyl and pyridyl amino carboxylates
11/11/1997	US5686579 Use of antibody/antigen interactions to protect biologically active proteins and peptides
11/11/1997	US5686578 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
11/11/1997	US5686489 Alpha hydroxyacid esters for skin aging
11/11/1997	US5686440 Containing lactic acid as a solubilizer and an additive
11/11/1997	US5686416 Bradykinin analogues; nona-, deca- and polypeptides
11/11/1997	US5686410 Polypeptide derivatives
11/11/1997	US5686278 Methods for enhanced retrovirus-mediated gene transfer
11/11/1997	US5686133 Gelatin and lecithin
11/11/1997	US5686115 Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
11/11/1997	US5686113 Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
11/11/1997	US5686110 Water soluble complex of an alkyl or olefinic end capped polyalkylene oxide and a water insoluble substance
11/11/1997	US5686106 Cellulose acetate phthalate enteric coating
11/11/1997	US5686105 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
11/11/1997	US5686104 Stable oral CI-981 formulation and process of preparing same
11/11/1997	US5686103 Liposomal product with a ligand having fucose as a terminal moiety
11/11/1997	US5686101 Phospholipid derivative and liposome containing it
11/11/1997	US5686098 Active substance patch for the release of estradiol to the skin
11/11/1997	US5686097 Hormone replacement therapy, glycerol monolaurate, lauryl lactate
11/11/1997	US5686089 Tissue moisturizing and antimicrobial compositions
11/11/1997	US5686087 Cosmetic and/or pharmaceutical formulations with an improved feeling on the skin based on mixed guerbet alcohols
11/11/1997	US5686072 Antitumor, anticarcinogenic, synergistic mixture of cd22 binding immunotoxin and cd19 binding antibody for killing b cells
11/11/1997	US5686071 Polymer affinity system for the delivery of cytotoxic material and other compounds to sites of disease
11/11/1997	US5686065 Topical siloxane sunscreen compositions having enhanced performance and safety
11/11/1997	US5686060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography
11/11/1997	US5686059 Cartilage matrix protein and methods for use
11/11/1997	CA2024502C Dosage form for administering oral hypoglycemic glipizide
11/06/1997	WO1997041439A1 RECEPTOR FOR UNDERIVATIZED, AQUEOUS SOLUBLE β(1-3)-GLUCAN
11/06/1997	WO1997040858A1 Novel dispersible lipid blends and uses therefor
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	WO1997040850A1 Erythropoietin solution preparation
11/06/1997	WO1997040839A1 Dna vaccine formulations
11/06/1997	WO1997040823A1 Oral pharmaceutical compositions containing sex hormones
11/06/1997	WO1997040818A1 Biologically active composition
11/06/1997	WO1997040792A1 Transdermal administration of steroid hormones using diethanolamides of c12-c18 fatty acids as permeation enhancers
11/06/1997	WO1997040701A1 Cross-linked protein gels and methods of making them
11/06/1997	WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997	WO1997040670A1 Low ph acidic compositions
11/06/1997	WO1997036616A3 Anti-tumour agent
11/06/1997	DE19617716A1 In wäßriger Lösung redispergierbare Polymerpulver In aqueous solution redispersible polymer powder
11/06/1997	DE19617487A1 Geschmacksverbesserung von Arzneimittelwirkstoffen Improve the taste of active pharmaceutical ingredients
11/06/1997	CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	CA2252617A1 Methods for delivering compounds into a cell
11/05/1997	EP0804921A1 Topical composition
11/05/1997	EP0804876A1 Iodine/resin disinfectant and a procedure for the preparation thereof
11/05/1997	EP0804603A1 Use of a bacterial component to enhance targeted delivery of polynucleotides to cells
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804579A1 Antibodies which bind to insect gut proteins and their use

1 ... 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 ... 1712